Advanced Regenerative Medicine Strategies for Treatment of Perianal Fistula in Crohn's Disease Publisher Pubmed



Nazari H^{1, 2, 3} ; Naei VY^{1, 2} ; Tabasi AH^{1, 2, 4} ; Badripour A^{1, 2} ; Asbagh RA^{1, 2} ; Keramati MR^{1, 2} ; Sharifi A^{1, 2} ; Behboudi B^{1, 2} ; Kazemeini A^{1, 2} ; Abbasi M⁵ ; Keshvari A^{1, 2} ; Tafti SMA^{1, 2} Show Affiliations
Source: Inflammatory Bowel Diseases Published:2022

Abstract

Regenerative medicine is an emerging therapeutic method that aims to reconstruct tissues and organs. This advanced therapeutic approach has demonstrated great potential in addressing the limitations of medical and surgical procedures for treating perineal fistula in patients with Crohn's disease. Recent developments in stem cell technology have led to a massive good manufacturing practices (GMPs) production of various stem cells, including mesenchymal and embryonic cells, along with induction of pluripotent stem cells to repair damaged tissues in the fistula. The recent advances in separation and purification of exosomes, as biologic nanovesicles carrying anti-inflammatory and regenerative agents, have made them powerful tools to treat this inflammatory disease. Further, tremendous advances in nanotechnology, biomaterials, and scaffold fabrication methods enable tissue engineering methods to synthesize tissue-like structures to assist surgical techniques. This review focuses on advanced regenerative-based methods including stem cell therapy, exosome therapy, and tissue engineering used in the treatment of perianal fistula. Relevant in vitro and in vivo studies and the latest innovations in implementation of regenerative medicine for this disease are also separately reviewed. Additionally, current challenges regarding implementation of g stem cells, exosomes, and tissue engineering methods for bridging the gaps between laboratory findings and clinic application will be discussed. © 2021 Crohn's & Colitis Foundation. Published by Oxford University Press. All rights reserved.